NYXH Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 1.97%, SMA50 -0.79%, SMA200 -20.52%). The stock’s 14-day RSI is 51.66 (neutral), while the ATR of 0.28 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -60.4% below its high and over 14.63% above its low. Average 10-day trading volume of 131.45 thousand shares is below the 3-month average of 269.54 thousand, indicating normal recent market interest.

Nyxoah S.A. has 37.44 million shares outstanding. The public float is 18.73 million shares, elevated short interest at 0.92% of float. This equals 241.91 thousand shares. The short ratio is 1.92 days. Institutional investors hold 39.11% of the float. Insiders own 41.73%.

Nyxoah S.A. generated EPS of -$2.48 over the past year. Five-year average earnings growth is -34.68%. Wall Street analysts project EPS growth of 4.46% annually over the next five years. The latest quarter delivered EPS of -$0.43. The next quarter is forecast at -$0.64. Next year's EPS is expected at -$11.28. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 3 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $11.00 to $3.00. The high target offers 558.68% upside. The low target suggests 79.64% downside. The mean target is $8.00. This offers 379.04% upside. Nyxoah S.A. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 12, 2026, missed forecasts by -21.05%. The prior quarter beat by 4.62%. Over the last six quarters, Apple has recorded several small beats. These include 6.52% in March 13, 2025.

Nyxoah S.A. (NASDAQ:NYXH) closed at $1.67 USD, gaining $0.04 (2.45%) from the previous close of $1.63. The stock is currently mid-range between its 52-week high and low $1.26 and $8.59. With a market capitalization of about $66.14 million, Nyxoah S.A. is classified as a micro-cap and shows market-like volatility (beta ~0.89). Key stats such as the average daily volume over the past year has been around 256.20 thousand shares, volume is running light vs its 52-week average. Headquartered in Mont-Saint-Guibert, WBR, Nyxoah S.A. operates in the Healthcare sector and the Medical - Specialties industry. Led by CEO Olivier Taelman, the company employs approximately 163 people and listed since April 28, 2021. Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA).

Nyxoah S.A. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$3.47. This means the shares are trading below this model’s fair value.

Nyxoah S.A. trades at a P/E ratio of -0.69, slightly below the S&P 500 average, with a price-to-sales ratio of 3.56 and a price-to-book ratio of 1.76 suggesting the stock is closer to book value. The P/FCF stands at -0.79, also above market averages.

Our AI price prediction model suggests that Nyxoah S.A. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -43.11%, with price expected at $0.95 by July 10, 2026, within a range of $0.52 to $1.41 3-Month Outlook: Projected fall of -50.3%, reaching $0.83 by September 24, 2026, with a range of $0.61 to $1.05. 1-Year Outlook: Projected loss of -32.34%, with price at $1.13 by June 25, 2027, within a range of $0.00 to $0.00.

Nyxoah S.A. (NASDAQ:NYXH) shares are flat 2.83% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Nyxoah S.A. trading at a premium to the broader market with a P/E of -0.69. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $15.86, suggesting 849.7% upside. Our AI forecast model points to short-term weakness (-43.11% over two weeks), a medium-term fall (-50.3% over three months), and a longer-term loss (-32.34% over one year), with expected trading ranges indicating moderate volatility.